Literature DB >> 17920517

Macrophage scavenger receptors and host-derived ligands.

Annette Plüddemann1, Claudine Neyen, Siamon Gordon.   

Abstract

The scavenger receptors are a large family of molecules that are structurally diverse and have been implicated in a range of functions. They are expressed by myeloid cells, selected endothelial cells and some epithelial cells and recognise many different ligands, including microbial pathogens as well as endogenous and modified host-derived molecules. This review will focus on the eight classes of scavenger receptors (class A-H) in terms of their structure, expression and recognition of host-derived ligands. Scavenger receptors have been implicated in a range of physiological and pathological processes, such as atherosclerosis and Alzheimer's disease, and function in adhesion and tissue maintenance. More recently, some of the scavenger receptors have been shown to mediate binding and endocytosis of chaperone proteins, such as the heat shock proteins, thereby playing an important role in antigen cross-presentation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920517     DOI: 10.1016/j.ymeth.2007.06.004

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  102 in total

1.  Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials.

Authors:  Bryan N Brown; Ricardo Londono; Stephen Tottey; Li Zhang; Kathryn A Kukla; Matthew T Wolf; Kerry A Daly; Janet E Reing; Stephen F Badylak
Journal:  Acta Biomater       Date:  2011-12-02       Impact factor: 8.947

Review 2.  Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come.

Authors:  Ayesha Murshid; Jianlin Gong; Mary Ann Stevenson; Stuart K Calderwood
Journal:  Expert Rev Vaccines       Date:  2011-11       Impact factor: 5.217

3.  SR-A, MARCO and TLRs differentially recognise selected surface proteins from Neisseria meningitidis: an example of fine specificity in microbial ligand recognition by innate immune receptors.

Authors:  Annette Plüddemann; Subhankar Mukhopadhyay; Marko Sankala; Silvana Savino; Mariagrazia Pizza; Rino Rappuoli; Karl Tryggvason; Siamon Gordon
Journal:  J Innate Immun       Date:  2008-09-11       Impact factor: 7.349

Review 4.  Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.

Authors:  Shann S Yu; Ryan A Ortega; Brendan W Reagan; John A McPherson; Hak-Joon Sung; Todd D Giorgio
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-10

5.  Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis.

Authors:  Tanu Goyal; Sona Mitra; Magomed Khaidakov; Xianwei Wang; Sandeep Singla; Zufeng Ding; Shijie Liu; Jawahar L Mehta
Journal:  Curr Atheroscler Rep       Date:  2012-01-29       Impact factor: 5.113

Review 6.  The role of innate immunity in atherogenesis.

Authors:  Karsten Hartvigsen; Meng-Yun Chou; Lotte F Hansen; Peter X Shaw; Sotirios Tsimikas; Christoph J Binder; Joseph L Witztum
Journal:  J Lipid Res       Date:  2008-12-22       Impact factor: 5.922

Review 7.  LOX-1, a new marker of risk and prognosis in coronary artery disease?

Authors:  Valter Lubrano; Silvana Balzan
Journal:  Mol Cell Biochem       Date:  2013-08-11       Impact factor: 3.396

8.  Circulating antibodies and macrophages as modulators of adenovirus pharmacology.

Authors:  Reeti Khare; Matthew L Hillestad; Zhili Xu; Andrew P Byrnes; Michael A Barry
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

Review 9.  Emerging roles for scavenger receptor SREC-I in immunity.

Authors:  Ayesha Murshid; Thiago J Borges; Stuart K Calderwood
Journal:  Cytokine       Date:  2015-03-09       Impact factor: 3.861

10.  Regulation of class A scavenger receptor-mediated cell adhesion and surface localization by PI3K: identification of a regulatory cytoplasmic motif.

Authors:  Jill Cholewa; Dejan Nikolic; Steven R Post
Journal:  J Leukoc Biol       Date:  2009-12-01       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.